Repurposing drugs for multi-target treatment of cytokine storm using machine learning

Abstract

Background: Cytokine Release Syndrome (CRS) is a major driver of acute organ failure in critical care settings, affecting approximately 49 million people and killing approximately 11 million people annually. Targeting multiple dysregulated feedback loops via single-molecule polypharmacology offers a promising strategy to blunt excessive immune activation and treat CRS-induced medical conditions such as sepsis. Methods: We used a computational workflow that combined machine-learning classification and molecular docking to identify multi-target modulators of NLRP3, IKBKB, JAK1, CCR5, and SIGMAR1. To eliminate data leakage, feature selection was strictly embedded within a 10-fold cross-validation loop. Candidates were structurally evaluated for binding affinity and active-site contact residues. Results: The model achieved an accuracy of 95.0% to 99.6% and an area under the receiver-operating curve (AUROC) of 0.995 to 1.000 across all five proteins, demonstrating robust generalization. Multiple compounds with average model-predicted scores above 0.50 across all five proteins were discovered. Docking analyses confirmed that the top candidates had favorable binding energetics, displaying stronger binding affinity than known protein inhibitors. Namely, Simeprevir had an average docking score of -10.3 kcal/mol. Shared key contact residues across drug candidates further support the validity of these docking scores and promise interesting in vitro work. Conclusion: Single-drug, multi-target inhibition effectively modulates interconnected inflammatory loops that drive the sepsis-related cytokine storm. This approach provides an alternative to multi-drug combination therapy in intensive care medicine.

The Mechanics of Delta Learning: Target Design for Generalizable Scientific Machine Learning
Kareem M. Gameel, Ihor Neporozhnii, Sjoerd Hoogland +1
arXiv23 Sep 2026PreprintCC BY-NC-ND 4.0Full textPhysical chemistry Computational physicsarXiv
Biochemical, structural, and functional characterization of the Nocardia asteroides dihydrofolate reductase: a primary target of anti-nocardiosis treatment
Julie Couston, Sébastien Lainé, Jérôme Feuillard +1
Biochimie5 Oct 2026Peer-reviewedCC BY 4.0Full textMaterials & polymersHAL
Deep learning-empowered metasurface design for complex target ISAR illusions
Cheng Zhu, Shaozhong Fu, Wang Xu +3
Optics Express20 Oct 2026Peer-reviewedPublisher termsMaterials & polymersCrossref
HierDTA: Hierarchical Structure-Aware Representation Learning for Drug–Target Affinity Prediction
Huangchao Xu, Baohua Zhang, Qian Liu +2
ACS Omega20 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral chemistryCrossref
Predicting fluorinated gas solubility in deep eutectic solvents using machine learning and deep learning approaches
Amir Hossein Sheikhshoaei, Amin Kazemi-Beydokhti, Jan J. Weigand +1
Scientific Reports27 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textCatalysisCrossref

Cite

BibTeX RIS

BibTeX

@misc{meng2026repurposing,
  title = {{Repurposing drugs for multi-target treatment of cytokine storm using machine learning}},
  author = {Leo Meng and Valentina L. Kouznetsova and Santosh Kesari and Igor F. Tsigelny},
  howpublished = {ChemRxiv},
  year = {2026},
  month = sep,
  doi = {10.26434/chemrxiv.15009692/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009692/v1},
  note = {CC BY},
}

RIS

TY  - UNPB
TI  - Repurposing drugs for multi-target treatment of cytokine storm using machine learning
AU  - Leo Meng
AU  - Valentina L. Kouznetsova
AU  - Santosh Kesari
AU  - Igor F. Tsigelny
PY  - 2026
DA  - 2026/09/30
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15009692/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009692/v1
AB  - Background: Cytokine Release Syndrome (CRS) is a major driver of acute organ failure in critical care settings, affecting approximately 49 million people and killing approximately 11 million people annually. Targeting multiple dysregulated feedback loops via single-molecule polypharmacology offers a promising strategy to blunt excessive immune activation and treat CRS-induced medical conditions such as sepsis. Methods: We used a computational workflow that combined machine-learning classification and molecular docking to identify multi-target modulators of NLRP3, IKBKB, JAK1, CCR5, and SIGMAR1. To eliminate data leakage, feature selection was strictly embedded within a 10-fold cross-validation loop. Candidates were structurally evaluated for binding affinity and active-site contact residues. Results: The model achieved an accuracy of 95.0% to 99.6% and an area under the receiver-operating curve (AUROC) of 0.995 to 1.000 across all five proteins, demonstrating robust generalization. Multiple compounds with average model-predicted scores above 0.50 across all five proteins were discovered. Docking analyses confirmed that the top candidates had favorable binding energetics, displaying stronger binding affinity than known protein inhibitors. Namely, Simeprevir had an average docking score of -10.3 kcal/mol. Shared key contact residues across drug candidates further support the validity of these docking scores and promise interesting in vitro work. Conclusion: Single-drug, multi-target inhibition effectively modulates interconnected inflammatory loops that drive the sepsis-related cytokine storm. This approach provides an alternative to multi-drug combination therapy in intensive care medicine.
ER  -

Abstract

Related

Cite